CN Patent

CN108939045A — 一种赖诺普利口服溶液及其制备方法

Assigned to Beijing Wanquan Dezhong Medical Biological Technology Co Ltd · Expires 2018-12-07 · 7y expired

What this patent protects

本发明提供了一种赖诺普利口服溶液及其制备方法，该制剂主要用于治疗原发性高血压。其优点在于药物以分子状态分散在介质中，分散度大、吸收快，能迅速发挥药效，有利于提高药物的生物利用度，且能提高患者用药的依从性，服用方便，易于分剂量，特别适用于老年患者，该口服溶液所述制备方法操作简单，无需特殊设备。

USPTO Abstract

本发明提供了一种赖诺普利口服溶液及其制备方法，该制剂主要用于治疗原发性高血压。其优点在于药物以分子状态分散在介质中，分散度大、吸收快，能迅速发挥药效，有利于提高药物的生物利用度，且能提高患者用药的依从性，服用方便，易于分剂量，特别适用于老年患者，该口服溶液所述制备方法操作简单，无需特殊设备。

Drugs covered by this patent

Patent Metadata

Patent number
CN108939045A
Jurisdiction
CN
Classification
—
Expires
2018-12-07
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Wanquan Dezhong Medical Biological Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.